| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |